FDA Food and Drug Administration - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves new type of non-opioid pain medication

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is

The Wall Street Journal on MSN · 2h

Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug

Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.

FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

FDA, migraine and Symbravo

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Business Insider · 5h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 4h

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

FDA upgrades Frito-Lay recall to highest priority

This chocolate recall has been upgraded to FDA’s highest risk level

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”

Houston Chronicle · 1d

FDA upgrades Frito-Lay recall to highest priority; Texas not affected

The Food and Drug Administration has upgraded a December recall of Classic Lays Potato Chips to Class 1, the highest priority designated by the agency.

Lays Classic Potato Chip recall upgraded to highest level. What to know

"Those with an allergy or...sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume the recalled product."

The FDA says it has approved a new non-addictive pain medication

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, ...

4don MSN

Food and Drug Administration wants to put nutrition labels front and center on food products

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

WISH-TV on MSN4h

FDA redefines ‘healthy’ food labels to help consumers make informed choices

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

Hosted on MSN18h

Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results